AL
UVXY icon

Aspiriant LLC’s ProShares Ultra VIX Short-Term Futures ETF UVXY Stock Holding History

Aspiriant LLC’s Portfolio UVXY Stock Details UVXY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-52
Closed -$60.5K – 295
2023
Q1 		$60.5K Buy
+52
New +$69.6K ﹤0.01% 272

Other funds holding UVXY

D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

Aspiriant LLC's UVXY Position: Q2 2023 in Review

Aspiriant LLC sold out of ProShares Ultra VIX Short-Term Futures ETF (UVXY) in Q2 2023, closing a stake of 52 shares — an estimated $60.5K sold.

Aspiriant LLC first reported a position in UVXY in Q1 2023 and held it in 1 quarter. The position peaked at $60.5K in Q1 2023. 38 funds tracked by Wall St. Rank hold UVXY as of Q2 2023.

  • Aspiriant LLC reported no remaining ProShares Ultra VIX Short-Term Futures ETF position as of Q2 2023 after selling out during the quarter.
  • Aspiriant LLC sold 52 ProShares Ultra VIX Short-Term Futures ETF shares in Q2 2023, an estimated $60.5K.
  • Aspiriant LLC first reported a position in ProShares Ultra VIX Short-Term Futures ETF in Q1 2023 and held it in 1 quarter.
  • Aspiriant LLC's ProShares Ultra VIX Short-Term Futures ETF position peaked at $60.5K in Q1 2023.
  • 38 funds tracked by Wall St. Rank held ProShares Ultra VIX Short-Term Futures ETF as of Q2 2023.

Based on Aspiriant LLC's 13F filing for Q2 2023, filed 19 Jul 2023.